The international #LighthouseII trial testing HIV drug Triumeq for #MND has been halted early after an interim analysis showed no survival benefit. A full analysis will follow. Thank you to all who took part.
Read more ⬇
ukmndri.org/2025/04/07/l...
Read more ⬇
ukmndri.org/2025/04/07/l...
Lighthouse II study of Triumeq for MND halted after interim analysis - UKMNDRI
The international Lighthouse II clinical trial investigating the HIV drug Triumeq as a potential treatment for MND has been halted early.
ukmndri.org
April 8, 2025 at 9:03 AM
The international #LighthouseII trial testing HIV drug Triumeq for #MND has been halted early after an interim analysis showed no survival benefit. A full analysis will follow. Thank you to all who took part.
Read more ⬇
ukmndri.org/2025/04/07/l...
Read more ⬇
ukmndri.org/2025/04/07/l...